1	De Vane CL, Ware MR, Emmanual NP, et al. The evaluation of the safety,efficacy, and physiological effects of fluvoxamine in social phobia. Presented at the 34th Annual Meeting of the American College of Neuropsychopharmacology; 1995 Dec 11-15; San Juan, Puerto Rico.
	2	van Vliet IM, den Boer JA, Westenberg HG. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994; 115: 1-2, 128-34.
	3	Stein MB, Fyer AJ, Davidson JRT, et al. Fluvoxamine treatment of social phobia(social anxiety disorder): A double-blind, placebo-controlled study. Am J Psychiatry 1999; 156 756-60.
	4	Schneier FR. Chin SJ, Hollander E, et al. Fluoxetine in social phobia. J Clin Psychopharmacol 1992; 12: 62-4.
	5	Black B, Uhde TW, Tancer ME. Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 1992; 12:293-5.
	6	van Ameringen M, Mancini C, Streiner DL. Fluoxetine efficacy in social phobia. J Clin Psychiatry 1993 ; 54 : 27-32.
	7	Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. Fluoxetine in social phobia: A double-blind, placebo-controlled pilot study. J Clin Psychopharmacol (2002 ; in press).
	8	van Ameringen M, Mancini C, Streiner D. Sertraline in social phobia. J Affect Disord 1994; 31:141-5.
	9	Martin EA. Pigott TA. Bernstein SE, et al. Sertraline in the treatment of patients with social phobia. Anxiety 1994/1995; 1: 291-7.
	10	Czepowicz VD, Johnson MR, Lydiard RB, et al. Sertraline in social phobia. J Clin Psychopharmacol 1995; 15:372-3.
	11	Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152:1368-71.
	12	Blomhoff S, Tangen Haug T, Hellstrom K, et al. Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. Br J Psychiatry 2001 ; 179 : 23-30.
	13	van Ameringen MA, Lane RM, Walker JR, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry 2001 158 : 275-81.
	14	Mancini C, Ameringen MV. Paroxetine in social phobia. J Clin Psychiatry 1996; 57 : 519-22.
	15	Stein MB, Chartier MJ, Hazen AL, et al. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation. J Clin Psychiatry 1996; 16 : 218-22.
	16	Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder). A randomized controlled trial. JAMA 1998 ; 280 : 708-13.
	17	Allgulander C. Paroxetine in social anxiety disorder: a randomized placebo-controlled study. Acta Psychiatr Scand 1999; 100:193-8.
	18	Baldwin D, Bobes J, Stein DJ, et al. Paroxetine in social phobia/social anxiety disorder. Randomized, double-blind, placebo-controlled study. Paroxetine Study Group. Br J Psychiatry 1999; 175: 120-6.
	19	Leopola U, Koponen H, Leinonen E. Citalopram in the treatment of social phobia; a report of three cases. Pharmacopsychiatry 1994 ; 27: 186-8.
	20	Bouwe C, Stein DJ. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. J Affective Disorders 1998; 49 : 79-82.
	21	Kasper S, Loft H, Smith JR. Escitalopram is efficacious and well tolerated in the treatment of social anxiety disorder. Poster : American Psychiatric Association ; 2002.
	22	Altamura AC, Pioli R, Vitto M, et al. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders. Int Clin Psychopharmacol 1999; 14 : 239-45.
	23	Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 1995 ; 31: 767-71.
	24	Simpson HB, Schneier FR, Campeas RB, et al. Imipramine in the treatment of social phobia. J Clin Psychopharmacol 1998; 18:132-5.
	25	Davidson JRT, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin  Psychopharmacology 1993; 13 : 423-8.
	26	Gelernter CH, Uhde TW, Cimbolic P, et al. Cognitive-behabioral and pharmacological treatments of social phobia. Arch Gen Psychiatry 1991 ; 48 : 938-45.
	27	Liebowitz MR, Schneier F, Campeas R, et al. Cognitive-behavioral and pharmacological treatment of social phobia: a controlled study. Arch Gen Psychiatry 1992 ; 49 : 290-300.
	28	Versiani M, Nardi AE, Mundium FD, et al. Phamacotherapy of social phobia: a controlled study with maclobemide and phenelzine. Br J Psychiatry 1992;161 :353-60.
	29	Varia I, Rauscher F. Treatment of generalized anxiety disorder with citalopram. Int Clin Psychopharmacol 2002; 17(3): 103-7.
	30	Rickels K, Pollack MH, Sheehan DV, et al. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 2000; 157 : 968-74.
	31	Gelenberg AJ, Lydiard RB, Rudolph RL, et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA 2000; 283 : 3082-8.
	32	Allgulander C, Hackett D, Salinas E. Venlafaxine extended release (ER) in the treatment of generalized anxiety disorder: twenty-four-week placebo-controlled dose-ranging study. Br J Psychiatry 2002; 180:185-6.
	33	Rocca P, Fonzo V, Scotta M, et al. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997 ; 95 : 444-50.
	34	Pollack MH, Zanineli R, Goddard A, et al. Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001 ; 62 : 350-7.
	35	Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993 ; 50 : 884-95.
	36	Hoehn-Saric R, McLeod DR, Zimmerli WD. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 1988 49 : 293-301.
	37	Davidson J, Kudler H, Smith R, et al. Treatment of postiraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990 ; 47 : 259-66.
	38	Davidson J, Pearistein T, Londborg P, et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 2001; 158:1974-81.
	39	Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001 ; 58 485-92.
	40	Frank JB, Kosten TR, Giller EL Jr, et al. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988; 145: 1289-91.
	41	Friedman MJ. Current and future drug treatment for posttraumatic stress disorder patient Psychiatr Ann 1998 ; 28 : 461-8.
	42	Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 2001; 158 :1982-8.
	43	Reist C, Kauffmann CD, Haier RJ, et al. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989; 146 : 513-6.
	44	van der Kolk BA. The drug treatment of post-traumatic stress disorder. J Affect Disord 1987; 13 203-13.
	45	van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994; 55 : 517-22.
	46	Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001 ; 62 : 860-8.